131 completed. 131 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 131 | Completed 131 |
Follow Lymphoproliferative Disorders: new trials by email Literature Review of Lymphoproliferative Disorders trials Research Report on Lymphoproliferative Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery Bridion 200 MG in 2 ML Injection, Pyridostigmine Bromide 5 MG/ML - Emergence Delirium, Strabismus | Phase 4 | Completed | Konkuk University Medical Center | 76 | 2023-12-01 | 2026-07-15 |
| A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy Mogamulizumab - Cutaneous T-Cell Lymphoma | Phase 4 | Completed | Kyowa Kirin China Pharmaceutical Co., Ltd. | 23 | 2023-05-29 | 2026-09-09 |
| A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia inotuzumab ozogamicin - Acute Lymphoblastic Leukemia | Phase 4 | Completed | Pfizer | 44 | 2023-02-24 | 2025-12-03 |
| Alternative Dosing Scheme of Pomalidomide 4 mg Every Other Day Versus Pomalidomide 2 mg and 4 mg Every Day; the POMAlternative Study Pomalidomide 4 mg every day in cycle 1, Pomalidomide 4 mg every other day in cycle 2, Pomalidomide 2 mg every day in cycle 2 - Multiple Myeloma in Relapse, Multiple Myeloma | Phase 4 | Completed | Amsterdam UMC, location VUmc | 12 | 2022-12-01 | 2025-04-22 |
| A Study of Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma Brentuximab vedotin - T-Cell Lymphoma | Phase 4 | Completed | Takeda | 10 | 2022-11-28 | 2025-09-18 |
| Home Based Daratumumab Administration for Patients With Multiple Myeloma Daratumumab and Hyaluronidase-fihj, Questionnaire Administration, Quality-of-Life Assessment - Plasma Cell Myeloma | Phase 4 | Completed | Thomas Jefferson University | 20 | 2022-11-08 | 2025-11-21 |
| Effectiveness and Safety of Guilu Erxian Oral Liquid in the Treatment of Oligozoospermia and Asthenospermia With Syndrome of Shen (Kidney) Essence Deficiency Guilu Erxian Oral Liquid, Wuzi Yanzong oral liquid - Mild and Moderate Oligozoospermia Asthenospermia or Oligoasthenospermia and the Syndrome Differentiation Type is Shen (Kidney) Essence Deficiency | Phase 4 | Completed | DongE E Jiao Coporation Limited | 360 | 2022-10-08 | 2025-12-08 |
| Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome Pegloticase, Rasburicase - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 4 | Completed | M.D. Anderson Cancer Center | 10 | 2022-04-05 | 2026-05-06 |
| Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting Telemedicine Visit, Vital sign measurements, Out-Patient Clinic Visit - Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma | Phase 4 | Completed | Vanderbilt-Ingram Cancer Center | 25 | 2021-12-02 | 2025-03-27 |
| Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma Acalabrutinib capsule - Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma | Phase 4 | Completed | AstraZeneca | 103 | 2021-07-14 | 2024-11-22 |
| Nalbuphine Versus Ketamine for Prevention of Emergence Agitation After Sevoflurane in Children Undergoing Tonsillectomy Nalbuphine Injection, Ketamine, Saline - Pediatric ALL, Pediatric Anesthesia | Phase 4 | Completed | Ain Shams University | 90 | 2021-03-25 | 2022-01-04 |
| Regional Anesthesia for Totally Awake Upper Limb Surgery in PEDiatric Population local anaesthetic injection - Surgery, Anesthesia, Local | Phase 4 | Completed | GCS Ramsay Santé pour l'Enseignement et la Recherche | 100 | 2020-10-14 | 2026-07-16 |
| Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation Melphalan Hydrochloride for Injection - Multiple Myeloma | Phase 4 | Completed | CASI Pharmaceuticals (China) Co., Ltd. | 67 | 2020-07-24 | 2024-05-23 |
| Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia RASBURICASE SR29142 - Lymphoma | Phase 4 | Completed | Sanofi | 50 | 2020-05-14 | 2022-04-25 |
| A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM) Ibrutinib - Waldenstrom Macroglobulinemia | Phase 4 | Completed | Janssen Research & Development, LLC | 17 | 2019-12-18 | 2025-05-25 |
| A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis Secukinumab - Psoriasis | Phase 4 | Completed | Saakshi Khattri | 20 | 2019-12-02 | 2022-04-11 |
| SUBLOCADE Rapid Initiation Extension Study Sublocade - Opioid Use Disorder, Severe, Opioid Use Disorder, Moderate | Phase 4 | Completed | Indivior Inc. | 17 | 2019-10-21 | 2025-03-25 |
| Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients Ixazomib, Lenalidomide - Multiple Myeloma | Phase 4 | Completed | Peking Union Medical College Hospital | 211 | 2019-09-24 | 2024-08-01 |
| Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma Drug: Carfilzomib + Dexamethasone, Drug: Carfilzomib + Lenalidomide + Dexamethasone - Relapsed Refractory Multiple Myeloma | Phase 4 | Completed | Amgen | 101 | 2019-09-16 | 2026-05-11 |
| A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients inotuzumab ozogamicin-dose level 2, Inotuzumab ozogamicin-dose level 1 - Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma | Phase 4 | Completed | Pfizer | 102 | 2019-07-01 | 2023-11-22 |
Showing 20 of 131. Sign in to see all of them.
Precursor Cell Lymphoblastic Leukemia-Lymphoma (30) · Multiple Myeloma (22) · Lymphoma, Follicular (19) · Lymphoma (16) · Lymphoma, Non-Hodgkin (16) · Recurrence (9) · Leukemia, Lymphocytic, Chronic, B-Cell (8) · Lymphoma, T-Cell, Cutaneous (7) · Leukemia (6) · Asthma (5) · Lymphoma, Large B-Cell, Diffuse (5) · Lymphoma, Mantle-Cell (5) · Sarcoidosis (5) · Waldenstrom Macroglobulinemia (5) · Hematologic Diseases (4)
Hemic and Lymphatic Diseases (131) · Immune System Diseases (129) · Immunoproliferative Disorders (122) · Neoplasms (120) · Neoplasms by Histologic Type (120) · Lymphatic Diseases (110) · Hematologic Diseases (69) · Lymphoma (47) · Leukemia, Lymphoid (38) · Leukemia (37) · Lymphoma, Non-Hodgkin (35) · Pathological Conditions, Signs and Symptoms (33) · Cardiovascular Diseases (29) · Vascular Diseases (28)
Cyclophosphamide (20) · Vincristine (16) · Cytarabine (15) · Dexamethasone (15) · Methotrexate (14) · Mercaptopurine (12) · Asparaginase (11) · Daunorubicin (10) · Doxorubicin (10) · Prednisolone (10) · Rituximab (10) · Granulocyte Colony-Stimulating Factor (8) · Etoposide (7) · Prednisone (7) · Zoledronic Acid (7)
PETHEMA Foundation (9) · Goethe University (5) · Novartis Pharmaceuticals (5) · GlaxoSmithKline (4) · Institute of Hematology & Blood Diseases Hospital, China (4) · Eisai Inc. (3) · Hoffmann-La Roche (3) · Pfizer (3) · Sanofi (3) · Amgen (2) · Biogen (2) · Children's Hospital of Michigan (2) · Depomed (2) · Genzyme, a Sanofi Company (2) · Johann Wolfgang Goethe University Hospital (2)
United States (43) · China (19) · Germany (19) · Spain (18) · United Kingdom (9) · France (8) · Sweden (8) · Italy (7) · Australia (6) · Austria (6) · Canada (6) · Czechia (6) · India (6) · Poland (6) · Russia (6)
Dieter Hoelzer, MD,PhD (4) · Shuhua Yi, Doc (4) · Bastida Pilar, Dr (2) · Dieter Hoelzer, MD, PhD (2) · Elyane Lombardy, M.D. (2)
PMID 19144982, PMID 22442346, PMID 22493293, PMID 23024237, PMID 23770157, PMID 27561722, PMID 28751559, PMID 14752084, PMID 15014526, PMID 15158091, PMID 15257960, PMID 17223475, PMID 18165618, PMID 18263672, PMID 19246088, PMID 19564304, PMID 20118030, PMID 20560291, PMID 21575927, PMID 21828124, PMID 21890336, PMID 21912321, PMID 21932110, PMID 21940824, PMID 22198540, PMID 22443312, PMID 23446769, PMID 23775967, PMID 23775972, PMID 23938061, PMID 24752047, PMID 24824768, PMID 25253770, PMID 25359988, PMID 25693055, PMID 26001791, PMID 26069291, PMID 26377300, PMID 26644410, PMID 27852260, PMID 28597542, PMID 28664750, PMID 29420116, PMID 31644328, PMID 32067048, PMID 32158186, PMID 32418789, PMID 32550864, PMID 32632956, PMID 33305842
2009 (3), 2014 (1), 2018 (1), 2019 (1), P30CA021765 (1), R01CA078957 (1), U01CA081445 (1)